Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome - PubMed (original) (raw)
Clinical Trial
. 2003 Sep;95(3):1005-10.
doi: 10.1152/japplphysiol.00366.2003. Epub 2003 May 23.
Affiliations
- PMID: 12766180
- DOI: 10.1152/japplphysiol.00366.2003
Free article
Clinical Trial
Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome
Martin Torriani et al. J Appl Physiol (1985). 2003 Sep.
Free article
Abstract
The human immunodeficiency virus (HIV)-lipodystrophy syndrome is characterized by abnormalities of lipid metabolism, glucose homeostasis, and fat distribution. Overaccumulation of intramuscular lipid may contribute to insulin resistance in this population. We examined 63 men: HIV positive with lipodystrophy (n = 22), HIV positive without lipodystrophy (n = 20), and age- and body mass index-matched HIV-negative controls (n = 21). Single-slice computed tomography was used to determine psoas muscle attenuation and visceral fat area. Plasma free fatty acids (FFA), lipid profile, and markers of glucose homeostasis were measured. Muscle attenuation was significantly decreased in subjects with lipodystrophy [median (interquartile range), 55.0 (51.0-58.3)] compared with subjects without lipodystrophy [57.0 (55.0-59.0); P = 0.05] and HIV-negative controls [59.5 (57.3-64.8); P < 0.01]. Among HIV-infected subjects, muscle attenuation correlated significantly with FFA (r = -0.38; P = 0.02), visceral fat (r = -0.49; P = 0.002), glucose (r = -0.38; P = 0.02) and insulin (r = -0.60; P = 0.0001) response to a 75-g oral glucose tolerance test. In forward stepwise regression analysis with psoas attenuation as the dependent variable, visceral fat (P = 0.02) and FFA (P < 0.05), but neither body mass index, subcutaneous fat, nor antiretroviral use, were strong independent predictors of muscle attenuation (r2 = 0.39 for model). Muscle attenuation (P = 0.02) and visceral fat (P = 0.02), but not BMI, subcutaneous fat, FFA, or antiretroviral use, were strong independent predictors of insulin response (area under the curve) to glucose challenge (r2 = 0.47 for model). These data demonstrate that decreased psoas muscle attenuation due to intramuscular fat accumulation may contribute significantly to hyperinsulinemia and insulin resistance in HIV-lipodystrophy patients. Further studies are needed to assess the mechanisms and consequences of intramuscular lipid accumulation in HIV-infected patients.
Similar articles
- Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution.
Meininger G, Hadigan C, Laposata M, Brown J, Rabe J, Louca J, Aliabadi N, Grinspoon S. Meininger G, et al. Metabolism. 2002 Feb;51(2):260-6. doi: 10.1053/meta.2002.29999. Metabolism. 2002. PMID: 11833059 - Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution.
Torriani M, Thomas BJ, Barlow RB, Librizzi J, Dolan S, Grinspoon S. Torriani M, et al. J Appl Physiol (1985). 2006 Feb;100(2):609-14. doi: 10.1152/japplphysiol.00797.2005. Epub 2005 Oct 13. J Appl Physiol (1985). 2006. PMID: 16223978 Free PMC article. - Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.
Samaras K, Wand H, Law M, Emery S, Cooper DA, Carr A. Samaras K, et al. Curr HIV Res. 2009 Jul;7(4):454-61. doi: 10.2174/157016209788680589. Curr HIV Res. 2009. PMID: 19601783 - Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment.
Villarroya F, Domingo P, Giralt M. Villarroya F, et al. Biochim Biophys Acta. 2010 Mar;1801(3):392-9. doi: 10.1016/j.bbalip.2009.09.018. Epub 2009 Sep 30. Biochim Biophys Acta. 2010. PMID: 19800025 Review. - Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophy.
Benedini S, Terruzzi I, Lazzarin A, Luzi L. Benedini S, et al. BioDrugs. 2008;22(2):101-12. doi: 10.2165/00063030-200822020-00003. BioDrugs. 2008. PMID: 18345707 Review.
Cited by
- Association Between Changes in Skeletal Muscle Quality and Prognosis in Postoperative Patients with Early Gastric Cancer.
Kobayashi S, Kamiya K, Miki T, Yamashita M, Noda T, Ueno K, Hotta K, Sakuraya M, Niihara M, Fukuda M, Hiki N. Kobayashi S, et al. Ann Surg Oncol. 2024 Aug 17. doi: 10.1245/s10434-024-16012-2. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39154156 - Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury.
Bhatia Kapoor P, Benjamin J, Tripathi H, Patidar Y, Maiwall R, Kumar G, Joshi YK, Sarin SK. Bhatia Kapoor P, et al. Turk J Gastroenterol. 2023 Apr;34(4):406-412. doi: 10.5152/tjg.2023.21964. Turk J Gastroenterol. 2023. PMID: 36620928 Free PMC article. - Frailty in older people living with HIV: current status and clinical management.
Kehler DS, Milic J, Guaraldi G, Fulop T, Falutz J. Kehler DS, et al. BMC Geriatr. 2022 Nov 30;22(1):919. doi: 10.1186/s12877-022-03477-7. BMC Geriatr. 2022. PMID: 36447144 Free PMC article. Review. - Sarcopenia is the independent predictor of mortality in critically ill patients with cirrhosis.
Khan S, Benjamin J, Maiwall R, Tripathi H, Kapoor PB, Shasthry V, Saluja V, Agrawal P, Thapar S, Kumar G. Khan S, et al. J Clin Transl Res. 2022 May 25;8(3):200-208. eCollection 2022 Jun 29. J Clin Transl Res. 2022. PMID: 35813898 Free PMC article. - Sex Differences in Non-AIDS Comorbidities Among People With Human Immunodeficiency Virus.
Pond RA, Collins LF, Lahiri CD. Pond RA, et al. Open Forum Infect Dis. 2021 Nov 3;8(12):ofab558. doi: 10.1093/ofid/ofab558. eCollection 2021 Dec. Open Forum Infect Dis. 2021. PMID: 34888399 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources